Myomo Inc Stock Performance

MYO Stock  USD 6.38  0.17  2.74%   
On a scale of 0 to 100, Myomo holds a performance score of 15. The company secures a Beta (Market Risk) of 0.93, which conveys possible diversification benefits within a given portfolio. Myomo returns are very sensitive to returns on the market. As the market goes up or down, Myomo is expected to follow. Please check Myomo's value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Myomo's current price movements will revert.

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Myomo Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Myomo displayed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(1.58)
Five Day Return
0.98
Year To Date Return
29.65
Ten Year Return
(97.20)
All Time Return
(97.20)
Last Split Factor
1:30
Dividend Date
2020-01-31
Last Split Date
2020-01-31
1
Disposition of 121 shares by Kovelman Harry of Myomo at 3.86 subject to Rule 16b-3
10/03/2024
2
Acquisition by Kovelman Harry of 8333 shares of Myomo at 0.6 subject to Rule 16b-3
10/10/2024
3
Myomo to Report Third Quarter Financial Results on November 6, 2024
10/30/2024
4
Disposition of 121 shares by Kovelman Harry of Myomo at 3.7 subject to Rule 16b-3
11/04/2024
5
Myomo Q3 2024 Earnings Preview
11/05/2024
6
Myomo earnings beat by 0.01, revenue topped estimates
11/06/2024
7
Earnings call Myomo reports record Q3 revenue, eyes future growth
11/07/2024
8
What is HC Wainwrights Estimate for Myomo FY2028 Earnings - MarketBeat
11/14/2024
9
Disposition of 146 shares by Kovelman Harry of Myomo at 3.21 subject to Rule 16b-3
11/29/2024
10
ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS Gold Standard Technology to Safeguard the Visual Health of Children and Adolesc...
12/03/2024
11
Myomo, Inc. Prices 15.0 Million Public Offering of Common Stock
12/05/2024
12
Myomo stock soars to 52-week high, hits 6.4 amid robust gains - Investing.com India
12/09/2024
Begin Period Cash Flow5.3 M
Free Cash Flow-6.3 M
  

Myomo Relative Risk vs. Return Landscape

If you would invest  410.00  in Myomo Inc on September 12, 2024 and sell it today you would earn a total of  230.00  from holding Myomo Inc or generate 56.1% return on investment over 90 days. Myomo Inc is generating 0.7752% of daily returns assuming volatility of 4.0566% on return distribution over 90 days investment horizon. In other words, 36% of stocks are less volatile than Myomo, and above 85% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Myomo is expected to generate 5.55 times more return on investment than the market. However, the company is 5.55 times more volatile than its market benchmark. It trades about 0.19 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of risk.

Myomo Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Myomo's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Myomo Inc, and traders can use it to determine the average amount a Myomo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1911

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMYO
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.06
  actual daily
36
64% of assets are more volatile

Expected Return

 0.78
  actual daily
15
85% of assets have higher returns

Risk-Adjusted Return

 0.19
  actual daily
15
85% of assets perform better
Based on monthly moving average Myomo is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myomo by adding it to a well-diversified portfolio.

Myomo Fundamentals Growth

Myomo Stock prices reflect investors' perceptions of the future prospects and financial health of Myomo, and Myomo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Myomo Stock performance.

About Myomo Performance

By examining Myomo's fundamental ratios, stakeholders can obtain critical insights into Myomo's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Myomo is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 108.65  130.72 
Return On Tangible Assets(0.56)(0.59)
Return On Capital Employed(0.90)(0.95)
Return On Assets(0.56)(0.59)
Return On Equity(0.91)(0.95)

Things to note about Myomo Inc performance evaluation

Checking the ongoing alerts about Myomo for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Myomo Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Myomo Inc appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 19.24 M. Reported Net Loss for the year was (8.15 M) with profit before taxes, overhead, and interest of 10.25 M.
Myomo Inc has about 5.35 M in cash with (6.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.46.
Latest headline from news.google.com: Myomo stock soars to 52-week high, hits 6.4 amid robust gains - Investing.com India
Evaluating Myomo's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Myomo's stock performance include:
  • Analyzing Myomo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Myomo's stock is overvalued or undervalued compared to its peers.
  • Examining Myomo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Myomo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Myomo's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Myomo's stock. These opinions can provide insight into Myomo's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Myomo's stock performance is not an exact science, and many factors can impact Myomo's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
0.835
Quarterly Revenue Growth
0.813
Return On Assets
(0.31)
Return On Equity
(0.83)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.